DMARDs Effective in Treating Juvenile Arthritis
- AHRQ comparative effectiveness report on treating juvenile arthritis:
- Affects up to 400 of every 100,000 children in the USA.
- Development of disease-modifying anti-rheumatic drugs (DMARDs) has improved treatment of arthritis.
- DMARDs more effective than traditional treatments in improving symptoms.
- Long-term effects unknown.
Image: The cover of the DMARDs report is shown.
Previous Slide Contents Next Slide